Evofem Biosciences, Inc. ("Evofem" or the "Company") today announced it has secured voting agreements with certain of its Series E-1 stockholders and convertible noteholders to ensure they will vote ...
Germany held a dominant revenue in the Western Europe Peri-Implantitis Treatment Market and is expected to grow with a CAGR of 2.3%. China occupies a leading value share in East Asia market in 2023 ...